Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas

Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas

The evaluation of the isocitrate dehydrogenase (IDH) mutation status in the glioma decision-making process has diagnostic, prognostic and therapeutic implications. The aim of this study was to evaluate whether conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) can...

Full description

Bibliographic Details
Main Authors:	Paola Feraco, Antonella Bacci, Patrizia Ferrazza, Luc van den Hauwe, Riccardo Pertile, Salvatore Girlando, Mattia Barbareschi, Cesare Gagliardo, Alessio Giuseppe Morganti, Benedetto Petralia
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Diagnostics
Subjects:	isocitrate dehydrogenase (IDH) mutation diffusion weighted imaging (DWI) apparent diffusion coefficient (ADC) anaplastic astrocytomas overall survival radiogenomics
Online Access:	https://www.mdpi.com/2075-4418/10/4/247

Similar Items

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
by: Lidia Gatto, et al.
Published: (2022-12-01)

Conventional MRI-Derived Biomarkers of Adult-Type Diffuse Glioma Molecular Subtypes: A Comprehensive Review
by: Paola Feraco, et al.
Published: (2022-10-01)

Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
by: Xiefeng Yang, et al.
Published: (2022-05-01)

Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
by: Andreas Stadlbauer, et al.
Published: (2021-04-01)

Expression of IDH1, ATRX, p53 in Diagnosis of Gliomas as Per 2016 WHO Classification
by: Lokesh Kumar, et al.
Published: (2023-07-01)

Regional ADC values of the morphologically normal canine brain
by: Lea Carisch, et al.
Published: (2023-11-01)

A rare brainstem anaplastic astrocytoma
by: You Rongjiao, et al.
Published: (2022-09-01)

Correlation Between Apparent Diffusion Coefficient and IDH-1/1p19q Genotype of Glioma
by: SUN Pengfei, et al.
Published: (2023-03-01)

Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
by: Kensuke Tateishi, et al.
Published: (2023-11-01)

A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report
by: Nurali Ashirov, et al.
Published: (2023-05-01)

Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
by: Swetha M. Nair, et al.
Published: (2024-04-01)

Computed Tomography and Magnetic Resonance Assessment of Choroid Plexus Xanthogranulomas
by: Sedat Altay
Published: (2020-11-01)

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
by: Santosh Sharma, et al.
Published: (2023-08-01)

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics
by: Ningfang Du, et al.
Published: (2022-05-01)

Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
by: Rishan Thimma Sudarsan, et al.
Published: (2023-04-01)

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
by: Seyyed Ali Hosseini, et al.
Published: (2023-02-01)

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging
by: Nils C. Nuessle, et al.
Published: (2021-08-01)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
by: Jonas Feldheim, et al.
Published: (2022-05-01)

Tuning the optimal diffusion-weighted MRI parameters on a 0.35-T MR-Linac for clinical implementation: A phantom study
by: Matteo Nardini, et al.
Published: (2022-11-01)

Predicting long-term outcomes for acute ischemic stroke using multi-model MRI radiomics and clinical variables
by: Lai Wei, et al.
Published: (2024-03-01)

Quantitative ADC: An Additional Tool in the Evaluation of Prostate Cancer?
by: Nicola Maria Lucarelli, et al.
Published: (2023-09-01)

Relationships and Qualitative Evaluation between Diffusion-Weighted Imaging and Pathologic Findings of Resected Lung Cancers
by: Katsuo Usuda, et al.
Published: (2020-05-01)

Value of quantitative apparent diffusion coefficients in differentiating low-grade gliomas from mixed neuronal-glial tumors
by: Amit Agarwal, et al.
Published: (2023-04-01)

The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
by: Jinzhi Fang, et al.
Published: (2023-03-01)

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
by: Kanish Mirchia, et al.
Published: (2020-07-01)

The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment
by: Kurdi M, et al.
Published: (2023-02-01)

Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting Bias
by: Yuxi Pang, et al.
Published: (2022-02-01)

Diffusion-Weighted Magnetic Resonance Imaging Value in the Detection and Differentiation of Bone Tumors and Tumor-Like Lesions
by: Mostafa Emara, et al.
Published: (2019-05-01)

A cystic anaplastic ependymoma mimicking a pilocytic astrocytoma
by: Nguyen Minh Duc, MD
Published: (2023-02-01)

The curious case of commitment to religion and prayer in extreme long term survival anaplastic astrocytoma patient
by: Goran Tasić, et al.
Published: (2023-03-01)

Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors
by: Peter Obel Otto, et al.
Published: (2023-12-01)

The Influence of Bowel Preparation on ADC Measurements: Comparison between Conventional DWI and DWIBS Sequences
by: Ilze Apine, et al.
Published: (2019-07-01)

External Validation of a Convolutional Neural Network for IDH Mutation Prediction
by: Iona Hrapșa, et al.
Published: (2022-04-01)

Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
by: Makoto Nakagawa, et al.
Published: (2022-06-01)

A contemporary molecular view of diffuse gliomas with implications for diagnosis
by: Jiabo Li, et al.
Published: (2020-01-01)

Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial Infection
by: Katsuo Usuda, et al.
Published: (2021-05-01)

MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting
by: Yu Sakai, et al.
Published: (2020-10-01)

Frequency of IDH1 mutation in adult-type diffuse astrocytic gliomas in a tertiary hospital in Kenya
by: Samuel Gakinya, et al.
Published: (2024-02-01)

<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01)

Implications of Concurrent <i>IDH1</i> and <i>IDH2</i> Mutations on Survival in Glioma—A Case Report and Systematic Review
by: Alexander Yuile, et al.
Published: (2022-10-01)